(Q82935275)
Statements
Targeting the MHC class II pathway of antigen presentation enhances immunogenicity and safety of allergen immunotherapy (English)
J M Martínez-Gómez
P Johansen
H Rose
M Steiner
G Senti
C Rhyner
28 November 2008